NSAIDs Market Report

Global NSAIDs Market Study Report 2022 Historical Trends, Growth, and Forecast to 2028

  • POSTDATE：Feb 24, 2022
  • PAGES：227
  • REPORT CODE：GMM769321
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • NSAIDs market report explains the definition, types, applications, major countries, and major players of the NSAIDs market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.

    The report contains qualitative and quantitative analysis of the entire industry.

    The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.

    By Player:

    • Pfizer

    • Novacap

    • Kopran

    • Reddy Pharmaceuticals

    • Johnson & Johnson

    • Bayer

    • Perrigo Company

    • Abbott

    • Verywell

    • Sun Pharmaceutical Industries

    • GlaxoSmithKline

    • Geri-Care Pharmaceuticals

    • Cigna

    • Merck Sharp & Dohme

    By Type:

    • Aspirin

    • Ibuprofen

    • Naproxen

    • Nabumetone

    • Others

    By End-User:

    • Back Pain Treatment

    • Osteoarthritis Treatment

    • Other Disease Treatment

    By Region:

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • UK

    • Spain

    • France

    • Italy

    • Denmark

    • Finland

    • Norway

    • Sweden

    • Poland

    • Russia

    • Turkey

    Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Pakistan

    • Bangladesh

    • Indonesia

    • Thailand

    • Singapore

    • Malaysia

    • Philippines

    • Vietnam

    • Others

    South America

    • Brazil

    • Colombia

    • Chile

    • Argentina

    • Venezuela

    • Peru

    • Puerto Rico

    • Ecuador

    • Others

    GCC

    • Bahrain

    • Kuwait

    • Oman

    • Qatar

    • Saudi Arabia

    • United Arab Emirates

    Africa

    • Nigeria

    • South Africa

    • Egypt

    • Algeriat

    • Others

    Oceania

    • Australia

    • New Zealand

  • TABLE OF CONTENT

    1. Global NSAIDs Executive Summary

    • 1.1 Introduction

    • 1.2 Market Panorama, 2022

    2 Coronavirus Impact

    • 2.1 NSAIDs Outlook to 2028- Original Forecasts

    • 2.2 NSAIDs Outlook to 2028- COVID-19 Affected Forecasts

    • 2.3 Impact on Industry

    3 Strategic Analytics to Boost Productivity and Profitability

    • 3.1 Potential Market Drivers and Opportunities

    • 3.2 New Challenges and Strategies

    • 3.3 Short Term and Long Term NSAIDs Market Trends

    4 Key Inferences

    5 Market Overview

    • 5.1 Current Market Scenario

    • 5.2 Porter's Five Forces Analysis

      • 5.2.1 Bargaining Power of Suppliers

      • 5.2.2 Bargaining Power of Consumers

      • 5.2.3 Threat of New Entrants

      • 5.2.4 Threat of Substitute Product and Services

      • 5.2.5 Competitive Rivalry within the Industry

    6 Global NSAIDs Market- Recent Developments

    • 6.1 NSAIDs Market News and Developments

    • 6.2 NSAIDs Market Deals Landscape

    7 NSAIDs Raw Materials and Cost Structure Analysis

    • 7.1 NSAIDs Key Raw Materials

    • 7.2 NSAIDs Price Trend of Key Raw Materials

    • 7.3 NSAIDs Key Suppliers of Raw Materials

    • 7.4 NSAIDs Market Concentration Rate of Raw Materials

    • 7.5 NSAIDs Cost Structure Analysis

      • 7.5.1 NSAIDs Raw Materials Analysis

      • 7.5.2 NSAIDs Labor Cost Analysis

      • 7.5.3 NSAIDs Manufacturing Expenses Analysis

    8 Global NSAIDs Import and Export Analysis (Top 10 Countries)

    • 8.1 Global NSAIDs Import by Region (Top 10 Countries) (2017-2028)

    • 8.2 Global NSAIDs Export by Region (Top 10 Countries) (2017-2028)

    9 Global NSAIDs Market Outlook by Types and Applications to 2022

    • 9.1 Global NSAIDs Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Aspirin Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Ibuprofen Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Naproxen Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global Nabumetone Consumption and Growth Rate (2017-2022)

      • 9.1.5 Global Others Consumption and Growth Rate (2017-2022)

    • 9.2 Global NSAIDs Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Back Pain Treatment Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Osteoarthritis Treatment Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Other Disease Treatment Consumption and Growth Rate (2017-2022)

    10 Region and Country-wise NSAIDs Market Analysis and Outlook till 2022

    • 10.1 Global NSAIDs Consumption (2017-2022)

    • 10.2 North America Consumption Analysis

      • 10.2.1 United States NSAIDs Consumption (2017-2022)

      • 10.2.2 Canada NSAIDs Consumption (2017-2022)

      • 10.2.3 Mexico NSAIDs Consumption (2017-2022)

    • 10.3 Europe Consumption Analysis

      • 10.3.1 Germany NSAIDs Consumption (2017-2022)

      • 10.3.2 UK NSAIDs Consumption (2017-2022)

      • 10.3.3 Spain NSAIDs Consumption (2017-2022)

      • 10.3.4 Belgium NSAIDs Consumption (2017-2022)

      • 10.3.5 France NSAIDs Consumption (2017-2022)

      • 10.3.6 Italy NSAIDs Consumption (2017-2022)

      • 10.3.7 Denmark NSAIDs Consumption (2017-2022)

      • 10.3.8 Finland NSAIDs Consumption (2017-2022)

      • 10.3.9 Norway NSAIDs Consumption (2017-2022)

      • 10.3.10 Sweden NSAIDs Consumption (2017-2022)

      • 10.3.11 Poland NSAIDs Consumption (2017-2022)

      • 10.3.12 Russia NSAIDs Consumption (2017-2022)

      • 10.3.13 Turkey NSAIDs Consumption (2017-2022)

    • 10.4 APAC Consumption Analysis

      • 10.4.1 China NSAIDs Consumption (2017-2022)

      • 10.4.2 Japan NSAIDs Consumption (2017-2022)

      • 10.4.3 India NSAIDs Consumption (2017-2022)

      • 10.4.4 South Korea NSAIDs Consumption (2017-2022)

      • 10.4.5 Pakistan NSAIDs Consumption (2017-2022)

      • 10.4.6 Bangladesh NSAIDs Consumption (2017-2022)

      • 10.4.7 Indonesia NSAIDs Consumption (2017-2022)

      • 10.4.8 Thailand NSAIDs Consumption (2017-2022)

      • 10.4.9 Singapore NSAIDs Consumption (2017-2022)

      • 10.4.10 Malaysia NSAIDs Consumption (2017-2022)

      • 10.4.11 Philippines NSAIDs Consumption (2017-2022)

      • 10.4.12 Vietnam NSAIDs Consumption (2017-2022)

    • 10.5 South America Consumption Analysis

      • 10.5.1 Brazil NSAIDs Consumption (2017-2022)

      • 10.5.2 Colombia NSAIDs Consumption (2017-2022)

      • 10.5.3 Chile NSAIDs Consumption (2017-2022)

      • 10.5.4 Argentina NSAIDs Consumption (2017-2022)

      • 10.5.5 Venezuela NSAIDs Consumption (2017-2022)

      • 10.5.6 Peru NSAIDs Consumption (2017-2022)

      • 10.5.7 Puerto Rico NSAIDs Consumption (2017-2022)

      • 10.5.8 Ecuador NSAIDs Consumption (2017-2022)

    • 10.6 GCC Consumption Analysis

      • 10.6.1 Bahrain NSAIDs Consumption (2017-2022)

      • 10.6.2 Kuwait NSAIDs Consumption (2017-2022)

      • 10.6.3 Oman NSAIDs Consumption (2017-2022)

      • 10.6.4 Qatar NSAIDs Consumption (2017-2022)

      • 10.6.5 Saudi Arabia NSAIDs Consumption (2017-2022)

      • 10.6.6 United Arab Emirates NSAIDs Consumption (2017-2022)

    • 10.7 Africa Consumption Analysis

      • 10.7.1 Nigeria NSAIDs Consumption (2017-2022)

      • 10.7.2 South Africa NSAIDs Consumption (2017-2022)

      • 10.7.3 Egypt NSAIDs Consumption (2017-2022)

      • 10.7.4 Algeria NSAIDs Consumption (2017-2022)

    • 10.8 Oceania Consumption Analysis

      • 10.8.1 Australia NSAIDs Consumption (2017-2022)

      • 10.8.2 New Zealand NSAIDs Consumption (2017-2022)

    11 Global NSAIDs Competitive Analysis

    • 11.1 Pfizer

      • 11.1.1 Pfizer Company Details

      • 11.1.2 Pfizer NSAIDs Sales, Price, Value and Gross Profit (2017-2022)

      • 11.1.3 Pfizer NSAIDs Main Business and Markets Served

      • 11.1.4 Pfizer NSAIDs Product Portfolio

      • 11.1.5 Recent Research and Development Strategies

    • 11.2 Novacap

      • 11.2.1 Novacap Company Details

      • 11.2.2 Novacap NSAIDs Sales, Price, Value and Gross Profit (2017-2022)

      • 11.2.3 Novacap NSAIDs Main Business and Markets Served

      • 11.2.4 Novacap NSAIDs Product Portfolio

      • 11.2.5 Recent Research and Development Strategies

    • 11.3 Kopran

      • 11.3.1 Kopran Company Details

      • 11.3.2 Kopran NSAIDs Sales, Price, Value and Gross Profit (2017-2022)

      • 11.3.3 Kopran NSAIDs Main Business and Markets Served

      • 11.3.4 Kopran NSAIDs Product Portfolio

      • 11.3.5 Recent Research and Development Strategies

    • 11.4 Reddy Pharmaceuticals

      • 11.4.1 Reddy Pharmaceuticals Company Details

      • 11.4.2 Reddy Pharmaceuticals NSAIDs Sales, Price, Value and Gross Profit (2017-2022)

      • 11.4.3 Reddy Pharmaceuticals NSAIDs Main Business and Markets Served

      • 11.4.4 Reddy Pharmaceuticals NSAIDs Product Portfolio

      • 11.4.5 Recent Research and Development Strategies

    • 11.5 Johnson & Johnson

      • 11.5.1 Johnson & Johnson Company Details

      • 11.5.2 Johnson & Johnson NSAIDs Sales, Price, Value and Gross Profit (2017-2022)

      • 11.5.3 Johnson & Johnson NSAIDs Main Business and Markets Served

      • 11.5.4 Johnson & Johnson NSAIDs Product Portfolio

      • 11.5.5 Recent Research and Development Strategies

    • 11.6 Bayer

      • 11.6.1 Bayer Company Details

      • 11.6.2 Bayer NSAIDs Sales, Price, Value and Gross Profit (2017-2022)

      • 11.6.3 Bayer NSAIDs Main Business and Markets Served

      • 11.6.4 Bayer NSAIDs Product Portfolio

      • 11.6.5 Recent Research and Development Strategies

    • 11.7 Perrigo Company

      • 11.7.1 Perrigo Company Company Details

      • 11.7.2 Perrigo Company NSAIDs Sales, Price, Value and Gross Profit (2017-2022)

      • 11.7.3 Perrigo Company NSAIDs Main Business and Markets Served

      • 11.7.4 Perrigo Company NSAIDs Product Portfolio

      • 11.7.5 Recent Research and Development Strategies

    • 11.8 Abbott

      • 11.8.1 Abbott Company Details

      • 11.8.2 Abbott NSAIDs Sales, Price, Value and Gross Profit (2017-2022)

      • 11.8.3 Abbott NSAIDs Main Business and Markets Served

      • 11.8.4 Abbott NSAIDs Product Portfolio

      • 11.8.5 Recent Research and Development Strategies

    • 11.9 Verywell

      • 11.9.1 Verywell Company Details

      • 11.9.2 Verywell NSAIDs Sales, Price, Value and Gross Profit (2017-2022)

      • 11.9.3 Verywell NSAIDs Main Business and Markets Served

      • 11.9.4 Verywell NSAIDs Product Portfolio

      • 11.9.5 Recent Research and Development Strategies

    • 11.10 Sun Pharmaceutical Industries

      • 11.10.1 Sun Pharmaceutical Industries Company Details

      • 11.10.2 Sun Pharmaceutical Industries NSAIDs Sales, Price, Value and Gross Profit (2017-2022)

      • 11.10.3 Sun Pharmaceutical Industries NSAIDs Main Business and Markets Served

      • 11.10.4 Sun Pharmaceutical Industries NSAIDs Product Portfolio

      • 11.10.5 Recent Research and Development Strategies

    • 11.11 GlaxoSmithKline

      • 11.11.1 GlaxoSmithKline Company Details

      • 11.11.2 GlaxoSmithKline NSAIDs Sales, Price, Value and Gross Profit (2017-2022)

      • 11.11.3 GlaxoSmithKline NSAIDs Main Business and Markets Served

      • 11.11.4 GlaxoSmithKline NSAIDs Product Portfolio

      • 11.11.5 Recent Research and Development Strategies

    • 11.12 Geri-Care Pharmaceuticals

      • 11.12.1 Geri-Care Pharmaceuticals Company Details

      • 11.12.2 Geri-Care Pharmaceuticals NSAIDs Sales, Price, Value and Gross Profit (2017-2022)

      • 11.12.3 Geri-Care Pharmaceuticals NSAIDs Main Business and Markets Served

      • 11.12.4 Geri-Care Pharmaceuticals NSAIDs Product Portfolio

      • 11.12.5 Recent Research and Development Strategies

    • 11.13 Cigna

      • 11.13.1 Cigna Company Details

      • 11.13.2 Cigna NSAIDs Sales, Price, Value and Gross Profit (2017-2022)

      • 11.13.3 Cigna NSAIDs Main Business and Markets Served

      • 11.13.4 Cigna NSAIDs Product Portfolio

      • 11.13.5 Recent Research and Development Strategies

    • 11.14 Merck Sharp & Dohme

      • 11.14.1 Merck Sharp & Dohme Company Details

      • 11.14.2 Merck Sharp & Dohme NSAIDs Sales, Price, Value and Gross Profit (2017-2022)

      • 11.14.3 Merck Sharp & Dohme NSAIDs Main Business and Markets Served

      • 11.14.4 Merck Sharp & Dohme NSAIDs Product Portfolio

      • 11.14.5 Recent Research and Development Strategies

    12 Global NSAIDs Market Outlook by Types and Applications to 2028

    • 12.1 Global NSAIDs Consumption Forecast and Growth Rate by Type (2022-2028)

      • 12.1.1 Global Aspirin Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.2 Global Ibuprofen Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.3 Global Naproxen Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.4 Global Nabumetone Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.5 Global Others Consumption Forecast and Growth Rate (2022-2028)

    • 12.2 Global NSAIDs Consumption Forecast and Growth Rate by Application (2022-2028)

      • 12.2.1 Global Back Pain Treatment Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.2 Global Osteoarthritis Treatment Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.3 Global Other Disease Treatment Consumption Forecast and Growth Rate (2022-2028)

    13 Country-wise NSAIDs Market Analysis and Outlook to 2028

    • 13.1 Global NSAIDs Consumption Forecast (2022-2028)

    • 13.2 North America Consumption Analysis

      • 13.2.1 United States NSAIDs Consumption Forecast (2022-2028)

      • 13.2.2 Canada NSAIDs Consumption Forecast (2022-2028)

      • 13.2.3 Mexico NSAIDs Consumption Forecast (2022-2028)

    • 13.3 Europe Consumption Analysis

      • 13.3.1 Germany NSAIDs Consumption Forecast (2022-2028)

      • 13.3.2 UK NSAIDs Consumption Forecast (2022-2028)

      • 13.3.3 Spain NSAIDs Consumption Forecast (2022-2028)

      • 13.3.4 Belgium NSAIDs Consumption Forecast (2022-2028)

      • 13.3.5 France NSAIDs Consumption Forecast (2022-2028)

      • 13.3.6 Italy NSAIDs Consumption Forecast (2022-2028)

      • 13.3.7 Denmark NSAIDs Consumption Forecast (2022-2028)

      • 13.3.8 Finland NSAIDs Consumption Forecast (2022-2028)

      • 13.3.9 Norway NSAIDs Consumption Forecast (2022-2028)

      • 13.3.10 Sweden NSAIDs Consumption Forecast (2022-2028)

      • 13.3.11 Poland NSAIDs Consumption Forecast (2022-2028)

      • 13.3.12 Russia NSAIDs Consumption Forecast (2022-2028)

      • 13.3.13 Turkey NSAIDs Consumption Forecast (2022-2028)

    • 13.4 APAC Consumption Analysis

      • 13.4.1 China NSAIDs Consumption Forecast (2022-2028)

      • 13.4.2 Japan NSAIDs Consumption Forecast (2022-2028)

      • 13.4.3 India NSAIDs Consumption Forecast (2022-2028)

      • 13.4.4 South Korea NSAIDs Consumption Forecast (2022-2028)

      • 13.4.5 Pakistan NSAIDs Consumption Forecast (2022-2028)

      • 13.4.6 Bangladesh NSAIDs Consumption Forecast (2022-2028)

      • 13.4.7 Indonesia NSAIDs Consumption Forecast (2022-2028)

      • 13.4.8 Thailand NSAIDs Consumption Forecast (2022-2028)

      • 13.4.9 Singapore NSAIDs Consumption Forecast (2022-2028)

      • 13.4.10 Malaysia NSAIDs Consumption Forecast (2022-2028)

      • 13.4.11 Philippines NSAIDs Consumption Forecast (2022-2028)

      • 13.4.12 Vietnam NSAIDs Consumption Forecast (2022-2028)

    • 13.5 South America Consumption Analysis

      • 13.5.1 Brazil NSAIDs Consumption Forecast (2022-2028)

      • 13.5.2 Colombia NSAIDs Consumption Forecast (2022-2028)

      • 13.5.3 Chile NSAIDs Consumption Forecast (2022-2028)

      • 13.5.4 Argentina NSAIDs Consumption Forecast (2022-2028)

      • 13.5.5 Venezuela NSAIDs Consumption Forecast (2022-2028)

      • 13.5.6 Peru NSAIDs Consumption Forecast (2022-2028)

      • 13.5.7 Puerto Rico NSAIDs Consumption Forecast (2022-2028)

      • 13.5.8 Ecuador NSAIDs Consumption Forecast (2022-2028)

    • 13.6 GCC Consumption Analysis

      • 13.6.1 Bahrain NSAIDs Consumption Forecast (2022-2028)

      • 13.6.2 Kuwait NSAIDs Consumption Forecast (2022-2028)

      • 13.6.3 Oman NSAIDs Consumption Forecast (2022-2028)

      • 13.6.4 Qatar NSAIDs Consumption Forecast (2022-2028)

      • 13.6.5 Saudi Arabia NSAIDs Consumption Forecast (2022-2028)

      • 13.6.6 United Arab Emirates NSAIDs Consumption Forecast (2022-2028)

    • 13.7 Africa Consumption Analysis

      • 13.7.1 Nigeria NSAIDs Consumption Forecast (2022-2028)

      • 13.7.2 South Africa NSAIDs Consumption Forecast (2022-2028)

      • 13.7.3 Egypt NSAIDs Consumption Forecast (2022-2028)

      • 13.7.4 Algeria NSAIDs Consumption Forecast (2022-2028)

    • 13.8 Oceania Consumption Analysis

      • 13.8.1 Australia NSAIDs Consumption Forecast (2022-2028)

      • 13.8.2 New Zealand NSAIDs Consumption Forecast (2022-2028)

    14 Conclusions


    The List of Tables and Figures

    • Table Definition of NSAIDs

    • Figure of NSAIDs Picture

    • Table Global NSAIDs Import by Region (Top 10 Countries) (2017-2028)

    • Table Global NSAIDs Export by Region (Top 10 Countries) (2017-2028)

    • Figure Global Aspirin Consumption and Growth Rate (2017-2022)

    • Figure Global Ibuprofen Consumption and Growth Rate (2017-2022)

    • Figure Global Naproxen Consumption and Growth Rate (2017-2022)

    • Figure Global Nabumetone Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Back Pain Treatment Consumption and Growth Rate (2017-2022)

    • Figure Global Osteoarthritis Treatment Consumption and Growth Rate (2017-2022)

    • Figure Global Other Disease Treatment Consumption and Growth Rate (2017-2022)

    • Figure Global NSAIDs Consumption by Country (2017-2022)

    • Table North America NSAIDs Consumption by Country (2017-2022)

    • Figure United States NSAIDs Consumption and Growth Rate (2017-2022)

    • Figure Canada NSAIDs Consumption and Growth Rate (2017-2022)

    • Figure Mexico NSAIDs Consumption and Growth Rate (2017-2022)

    • Table Europe NSAIDs Consumption by Country (2017-2022)

    • Figure Germany NSAIDs Consumption and Growth Rate (2017-2022)

    • Figure UK NSAIDs Consumption and Growth Rate (2017-2022)

    • Figure Spain NSAIDs Consumption and Growth Rate (2017-2022)

    • Figure Belgium NSAIDs Consumption and Growth Rate (2017-2022)

    • Figure France NSAIDs Consumption and Growth Rate (2017-2022)

    • Figure Italy NSAIDs Consumption and Growth Rate (2017-2022)

    • Figure Denmark NSAIDs Consumption and Growth Rate (2017-2022)

    • Figure Finland NSAIDs Consumption and Growth Rate (2017-2022)

    • Figure Norway NSAIDs Consumption and Growth Rate (2017-2022)

    • Figure Sweden NSAIDs Consumption and Growth Rate (2017-2022)

    • Figure Poland NSAIDs Consumption and Growth Rate (2017-2022)

    • Figure Russia NSAIDs Consumption and Growth Rate (2017-2022)

    • Figure Turkey NSAIDs Consumption and Growth Rate (2017-2022)

    • Table APAC NSAIDs Consumption by Country (2017-2022)

    • Figure China NSAIDs Consumption and Growth Rate (2017-2022)

    • Figure Japan NSAIDs Consumption and Growth Rate (2017-2022)

    • Figure India NSAIDs Consumption and Growth Rate (2017-2022)

    • Figure South Korea NSAIDs Consumption and Growth Rate (2017-2022)

    • Figure Pakistan NSAIDs Consumption and Growth Rate (2017-2022)

    • Figure Bangladesh NSAIDs Consumption and Growth Rate (2017-2022)

    • Figure Indonesia NSAIDs Consumption and Growth Rate (2017-2022)

    • Figure Thailand NSAIDs Consumption and Growth Rate (2017-2022)

    • Figure Singapore NSAIDs Consumption and Growth Rate (2017-2022)

    • Figure Malaysia NSAIDs Consumption and Growth Rate (2017-2022)

    • Figure Philippines NSAIDs Consumption and Growth Rate (2017-2022)

    • Figure Vietnam NSAIDs Consumption and Growth Rate (2017-2022)

    • Table South America NSAIDs Consumption by Country (2017-2022)

    • Figure Brazil NSAIDs Consumption and Growth Rate (2017-2022)

    • Figure Colombia NSAIDs Consumption and Growth Rate (2017-2022)

    • Figure Chile NSAIDs Consumption and Growth Rate (2017-2022)

    • Figure Argentina NSAIDs Consumption and Growth Rate (2017-2022)

    • Figure Venezuela NSAIDs Consumption and Growth Rate (2017-2022)

    • Figure Peru NSAIDs Consumption and Growth Rate (2017-2022)

    • Figure Puerto Rico NSAIDs Consumption and Growth Rate (2017-2022)

    • Figure Ecuador NSAIDs Consumption and Growth Rate (2017-2022)

    • Table GCC NSAIDs Consumption by Country (2017-2022)

    • Figure Bahrain NSAIDs Consumption and Growth Rate (2017-2022)

    • Figure Kuwait NSAIDs Consumption and Growth Rate (2017-2022)

    • Figure Oman NSAIDs Consumption and Growth Rate (2017-2022)

    • Figure Qatar NSAIDs Consumption and Growth Rate (2017-2022)

    • Figure Saudi Arabia NSAIDs Consumption and Growth Rate (2017-2022)

    • Figure United Arab Emirates NSAIDs Consumption and Growth Rate (2017-2022)

    • Table Africa NSAIDs Consumption by Country (2017-2022)

    • Figure Nigeria NSAIDs Consumption and Growth Rate (2017-2022)

    • Figure South Africa NSAIDs Consumption and Growth Rate (2017-2022)

    • Figure Egypt NSAIDs Consumption and Growth Rate (2017-2022)

    • Figure Algeria NSAIDs Consumption and Growth Rate (2017-2022)

    • Table Oceania NSAIDs Consumption by Country (2017-2022)

    • Figure Australia NSAIDs Consumption and Growth Rate (2017-2022)

    • Figure New Zealand NSAIDs Consumption and Growth Rate (2017-2022)

    • Table Pfizer Company Details

    • Table Pfizer NSAIDs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Pfizer NSAIDs Main Business and Markets Served

    • Table Pfizer NSAIDs Product Portfolio

    • Table Novacap Company Details

    • Table Novacap NSAIDs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Novacap NSAIDs Main Business and Markets Served

    • Table Novacap NSAIDs Product Portfolio

    • Table Kopran Company Details

    • Table Kopran NSAIDs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Kopran NSAIDs Main Business and Markets Served

    • Table Kopran NSAIDs Product Portfolio

    • Table Reddy Pharmaceuticals Company Details

    • Table Reddy Pharmaceuticals NSAIDs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Reddy Pharmaceuticals NSAIDs Main Business and Markets Served

    • Table Reddy Pharmaceuticals NSAIDs Product Portfolio

    • Table Johnson & Johnson Company Details

    • Table Johnson & Johnson NSAIDs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Johnson & Johnson NSAIDs Main Business and Markets Served

    • Table Johnson & Johnson NSAIDs Product Portfolio

    • Table Bayer Company Details

    • Table Bayer NSAIDs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bayer NSAIDs Main Business and Markets Served

    • Table Bayer NSAIDs Product Portfolio

    • Table Perrigo Company Company Details

    • Table Perrigo Company NSAIDs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Perrigo Company NSAIDs Main Business and Markets Served

    • Table Perrigo Company NSAIDs Product Portfolio

    • Table Abbott Company Details

    • Table Abbott NSAIDs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Abbott NSAIDs Main Business and Markets Served

    • Table Abbott NSAIDs Product Portfolio

    • Table Verywell Company Details

    • Table Verywell NSAIDs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Verywell NSAIDs Main Business and Markets Served

    • Table Verywell NSAIDs Product Portfolio

    • Table Sun Pharmaceutical Industries Company Details

    • Table Sun Pharmaceutical Industries NSAIDs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sun Pharmaceutical Industries NSAIDs Main Business and Markets Served

    • Table Sun Pharmaceutical Industries NSAIDs Product Portfolio

    • Table GlaxoSmithKline Company Details

    • Table GlaxoSmithKline NSAIDs Sales, Price, Value and Gross Profit (2017-2022)

    • Table GlaxoSmithKline NSAIDs Main Business and Markets Served

    • Table GlaxoSmithKline NSAIDs Product Portfolio

    • Table Geri-Care Pharmaceuticals Company Details

    • Table Geri-Care Pharmaceuticals NSAIDs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Geri-Care Pharmaceuticals NSAIDs Main Business and Markets Served

    • Table Geri-Care Pharmaceuticals NSAIDs Product Portfolio

    • Table Cigna Company Details

    • Table Cigna NSAIDs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Cigna NSAIDs Main Business and Markets Served

    • Table Cigna NSAIDs Product Portfolio

    • Table Merck Sharp & Dohme Company Details

    • Table Merck Sharp & Dohme NSAIDs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Merck Sharp & Dohme NSAIDs Main Business and Markets Served

    • Table Merck Sharp & Dohme NSAIDs Product Portfolio

    • Figure Global Aspirin Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Ibuprofen Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Naproxen Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Nabumetone Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Back Pain Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Osteoarthritis Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Other Disease Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global NSAIDs Consumption Forecast by Country (2022-2028)

    • Table North America NSAIDs Consumption Forecast by Country (2022-2028)

    • Figure United States NSAIDs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Canada NSAIDs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Mexico NSAIDs Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe NSAIDs Consumption Forecast by Country (2022-2028)

    • Figure Germany NSAIDs Consumption Forecast and Growth Rate (2022-2028)

    • Figure UK NSAIDs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Spain NSAIDs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Belgium NSAIDs Consumption Forecast and Growth Rate (2022-2028)

    • Figure France NSAIDs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Italy NSAIDs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Denmark NSAIDs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Finland NSAIDs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Norway NSAIDs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Sweden NSAIDs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Poland NSAIDs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Russia NSAIDs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Turkey NSAIDs Consumption Forecast and Growth Rate (2022-2028)

    • Table APAC NSAIDs Consumption Forecast by Country (2022-2028)

    • Figure China NSAIDs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan NSAIDs Consumption Forecast and Growth Rate (2022-2028)

    • Figure India NSAIDs Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea NSAIDs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Pakistan NSAIDs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Bangladesh NSAIDs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Indonesia NSAIDs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Thailand NSAIDs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Singapore NSAIDs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Malaysia NSAIDs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Philippines NSAIDs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Vietnam NSAIDs Consumption Forecast and Growth Rate (2022-2028)

    • Table South America NSAIDs Consumption Forecast by Country (2022-2028)

    • Figure Brazil NSAIDs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Colombia NSAIDs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Chile NSAIDs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Argentina NSAIDs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Venezuela NSAIDs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Peru NSAIDs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Puerto Rico NSAIDs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Ecuador NSAIDs Consumption Forecast and Growth Rate (2022-2028)

    • Table GCC NSAIDs Consumption Forecast by Country (2022-2028)

    • Figure Bahrain NSAIDs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Kuwait NSAIDs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Oman NSAIDs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Qatar NSAIDs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Saudi Arabia NSAIDs Consumption Forecast and Growth Rate (2022-2028)

    • Figure United Arab Emirates NSAIDs Consumption Forecast and Growth Rate (2022-2028)

    • Table Africa NSAIDs Consumption Forecast by Country (2022-2028)

    • Figure Nigeria NSAIDs Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Africa NSAIDs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Egypt NSAIDs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Algeria NSAIDs Consumption Forecast and Growth Rate (2022-2028)

    • Table Oceania NSAIDs Consumption Forecast by Country (2022-2028)

    • Figure Australia NSAIDs Consumption Forecast and Growth Rate (2022-2028)

    • Figure New Zealand NSAIDs Consumption Forecast and Growth Rate (2022-2028)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US